-

ATEC to Present at Upcoming Conferences

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences:

  • The Bank of America Healthcare Conference at the Encore Hotel in Las Vegas, NV, on May 15, 2024, at 1:40pm PT
  • The Barclays MedTech West Coast Bus Tour at the Fairmont Grand in Del Mar, CA, on May 20, 2024, at 8:00am PT
  • The Wells Fargo West Coast MedTech Tour at the Lodge at Torrey Pines in La Jolla, CA, on May 30, 2024, at 11:40am PT
  • The Jefferies Health Care Conference in New York, NY, on June 5, 2024, at 4:00pm ET

The live webcasts will be accessible on ATEC’s Investor Relations website.

Inducement Awards Granted

As an inducement material to accepting employment with the Company, and in accordance with Nasdaq Listing Rule 5635(c)(4), ATEC today announced that the independent Compensation Committee of the Board of Directors has approved aggregate grants to 14 new employees (who are not executive officers) of, collectively, 14,024 restricted stock units (“RSUs”) under the Company’s 2016 Employment Inducement Award Plan. The RSUs will vest in equal annual installments on each of the first four anniversaries of the grant date, provided that the recipient remains continuously employed by ATEC as of such vesting date. In addition, the RSUs will vest fully upon a change of control of ATEC.

About ATEC

ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC’s Organic Innovation MachineTM is focused on developing new approaches that integrate seamlessly with the Company’s expanding AlphaInformatiX Platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC’s vision is to become the Standard Bearer in Spine. For more information, visit us at www.atecspine.com.

Contacts

Investor/Media Contact: 
Tina Jacobsen, CFA 
Investor Relations 
(760) 494-6790 
investorrelations@atecspine.com

Company Contact: 
J. Todd Koning 
Chief Financial Officer 
Alphatec Holdings, Inc. 
investorrelations@atecspine.com

Alphatec Holdings, Inc.

NASDAQ:ATEC

Release Versions

Contacts

Investor/Media Contact: 
Tina Jacobsen, CFA 
Investor Relations 
(760) 494-6790 
investorrelations@atecspine.com

Company Contact: 
J. Todd Koning 
Chief Financial Officer 
Alphatec Holdings, Inc. 
investorrelations@atecspine.com

Social Media Profiles
More News From Alphatec Holdings, Inc.

ATEC to Report First Quarter 2025 Financial Results on May 1, 2025

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2025 financial results on May 1, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC’s Corporate Website. Dial-In To dial into the live...

ATEC Prices Upsized $350.0 Million Convertible Senior Notes Offering

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the pricing of its offering of $350,000,000 aggregate principal amount of 0.75% convertible senior notes due 2030 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from t...

ATEC Announces Proposed Convertible Senior Notes Offering

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced its intention to offer, subject to market and other conditions, $300,000,000 aggregate principal amount of convertible senior notes due 2030 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). ATEC also e...
Back to Newsroom